The store will not work correctly when cookies are disabled.
We use cookies for optimal website function and to better serve our customers. By continuing to browse you agree to the storing of cookies on your device. See our privacy policy for details.
Allow cookies Deny
CAS NO.:1863905-38-7; PF-06737007 is a clinical-stage key intermediate for metabolic disease therapeutics. ChemShuttle, a custom synthesis company, synthesizes this compound (CAS NO.:1863905-38-7) under cGMP conditions for preclinical development. As a key intermediate, it supports the production of glucagon receptor antagonists. The company’s custom synthesis services ensure scalable and compliant manufacturing of key intermediates, meeting the stringent demands of pharmaceutical partners.